Perception of Harmfulness of Various Tobacco Products and E-Cigarettes in Poland: A Nationwide Cross-Sectional Survey
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Desing and Population
2.2. Questionnaire and Study Measures
2.3. Statistical Analysis
3. Results
3.1. Characteristics of the Study Population
3.2. Awareness of the Health Effects of Using Tobacco and E-Cigarettes
3.3. Harm Perceptions of Various Tobacco Products and E-Cigarettes
3.4. Associates of Harm Perceptions of Various Tobacco Products and E-Cigarettes
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Eriksen, M.; Mackay, J.; Schluger, N.W.; Gomeshtapeh, F.I.; Drope, J. The Tobacco Atlas, 5th ed.; American Cancer Society: Atlanta, GA, USA, 2015. [Google Scholar]
- World Health Organization (WHO). Tobacco. Available online: https://www.who.int/news-room/fact-sheets/detail/tobacco (accessed on 14 July 2021).
- Dobson, A.J.; Alexander, H.M.; Heller, R.F.; Lloyd, D.M. How soon after quitting smoking does risk of heart attack decline? J. Clin. Epidemiol. 1991, 44, 1247–1253. [Google Scholar] [CrossRef]
- U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General; U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, GA, USA, 2014.
- Goodchild, M.; Nargis, N.; Tursan d’Espaignet, E. Global economic cost of smoking-attributable diseases. Tob. Control 2018, 27, 58–64. [Google Scholar] [CrossRef] [PubMed]
- European Commission. Special Eurobarometer 458—Attitudes of Europeans towards Tobacco and Electronic Cigarettes. Available online: https://publications.europa.eu/en/publication-detail/-/publication/2f01a3d1-0af2-11e8-966a-01aa75ed71a1/language-en (accessed on 14 July 2021).
- Bilano, V.; Gilmour, S.; Moffiet, T.; d’Espaignet, E.T.; Stevens, G.A.; Commar, A.; Tuyl, F.; Hudson, I.; Shibuya, K. Global trends and projections for tobacco use, 1990–2025: An analysis of smoking indicators from the WHO Comprehensive Information Systems for Tobacco Control. Lancet 2015, 385, 966–976. [Google Scholar] [CrossRef]
- Lim, S.S.; Allen, K.; Bhutta, Z.A.; Dandona, L.; Forouzanfar, M.H.; Fullman, N.; Gething, P.W.; Goldberg, E.M.; Hay, S.I.; Holmberg, M.; et al. GBD 2015 SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: A baseline analysis from the Global Burden of Disease Study 2015. Lancet 2016, 388, 1813–1850. [Google Scholar] [CrossRef] [Green Version]
- Jankowski, M.; Brożek, G.M.; Lawson, J.; Skoczyński, S.; Majek, P.; Zejda, J.E. New ideas, old problems? Heated tobacco products-A systematic review. Int. J. Occup. Med. Environ. Health 2019, 32, 595–634. [Google Scholar] [CrossRef]
- Collins, L.; Glasser, A.M.; Abudayyeh, H.; Pearson, J.L.; Villanti, A.C. E-Cigarette Marketing and Communication: How E-Cigarette Companies Market E-Cigarettes and the Public Engages with E-cigarette Information. Nicotine Tob. Res. 2019, 21, 14–24. [Google Scholar] [CrossRef]
- Benowitz, N.L.; Burbank, A.D. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends. Cardiovasc. Med. 2016, 26, 515–523. [Google Scholar] [CrossRef] [Green Version]
- Skotsimara, G.; Antonopoulos, A.S.; Oikonomou, E.; Siasos, G.; Ioakeimidis, N.; Tsalamandris, S.; Charalambous, G.; Galiatsatos, N.; Vlachopoulos, C.; Tousoulis, D. Cardiovascular effects of electronic cigarettes: A systematic review and meta-analysis. Eur. J. Prev. Cardiol. 2019, 26, 1219–1228. [Google Scholar] [CrossRef]
- Benowitz, N.L.; Fraiman, J.B. Cardiovascular effects of electronic cigarettes. Nat. Rev. Cardiol. 2017, 14, 447–456. [Google Scholar] [CrossRef]
- Alzahrani, T.; Pena, I.; Temesgen, N.; Glantz, S.A. Association Between Electronic Cigarette Use and Myocardial Infarction. Am. J. Prev. Med. 2018, 55, 455–461. [Google Scholar] [CrossRef] [PubMed]
- Wilson, S.; Partos, T.; McNeill, A.; Brose, L.S. Harm perceptions of e-cigarettes and other nicotine products in a UK sample. Addiction 2019, 114, 879–888. [Google Scholar] [CrossRef] [Green Version]
- Czoli, C.D.; Fong, G.T.; Mays, D.; Hammond, D. How do consumers perceive differences in risk across nicotine products? A review of relative risk perceptions across smokeless tobacco, e-cigarettes, nicotine replacement therapy and combustible cigarettes. Tob. Control 2017, 26, e49–e58. [Google Scholar] [CrossRef] [PubMed]
- Pinkas, J.; Kaleta, D.; Zgliczyński, W.S.; Lusawa, A.; Wrześniewska-Wal, I.; Wierzba, W.; Gujski, M.; Jankowski, M. The Prevalence of Tobacco and E-Cigarette Use in Poland: A 2019 Nationwide Cross-Sectional Survey. Int. J. Environ. Res. Public Health 2019, 16, 4820. [Google Scholar] [CrossRef] [Green Version]
- Zatoński, W.A.; Zatoński, M.; Janik-Koncewicz, K.; Połtyn-Zaradna, K.; Wijatkowska, K.; Marciniak, A. Hundred years of cigarette smoking in Poland: Three phases of the tobacco epidemic. J. Health Inequal. 2017, 3, 118–122. [Google Scholar] [CrossRef]
- Tutka, P.; Vinnikov, D.; Courtney, R.J.; Benowitz, N.L. Cytisine for nicotine addiction treatment: A review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation. Addiction 2019, 114, 1951–1969. [Google Scholar] [CrossRef] [PubMed]
- Pinkas, J.; Szymański, J.; Poznański, D.; Wierzba, W. Smoke-free policy in Poland on the example of the implementation into national law of the European Parliament and Council Directive 2014/40/EU of 3 April 2014 on the approximation of laws, regulations and administrative provisions of the Member States concerning the production, presentation and sale of tobacco and related products, and repealing Directive 2001/37/WE. Ann. Agric. Environ. Med. 2016, 23, 395–398. [Google Scholar] [PubMed]
- Fong, G.T.; Elton-Marshall, T.; Driezen, P.; Kaufman, A.R.; Cummings, K.M.; Choi, K.; Kwan, J.; Koblitz, A.; Hyland, A.; Bansal-Travers, M.; et al. U.S. adult perceptions of the harmfulness of tobacco products: Descriptive findings from the 2013–14 baseline wave 1 of the path study. Addict. Behav. 2019, 91, 180–187. [Google Scholar] [CrossRef]
- Milcarz, M.; Polańska, K.; Bak-Romaniszyn, L.; Kaleta, D. How Social Care Beneficiaries in Poland Rate Relative Harmfulness of Various Tobacco and Nicotine-Containing Products. Int. J. Environ. Res. Public Health 2017, 14, 1029. [Google Scholar] [CrossRef] [Green Version]
- Kaleta, D.; Polanska, K.; Bak-Romaniszyn, L.; Wojtysiak, P. Perceived Relative Harm of Selected Cigarettes and Non-Cigarette Tobacco Products—A Study of Young People from a Socio-Economically Disadvantaged Rural Area in Poland. Int. J. Environ. Res. Public Health 2016, 13, 885. [Google Scholar] [CrossRef] [Green Version]
- Majek, P.; Jankowski, M.; Nowak, B.; Macherski, M.; Nowak, M.; Gil, A.; Nakiela, P.; Lewicka, B.; Lawson, J.A.; Zejda, J.E.; et al. The Frequency of Use and Harm Perception of Heated Tobacco Products (HTPs): The 2019 Cross-Sectional Survey among Medical Students from Poland. Int. J. Environ. Res. Public Health 2021, 18, 3381. [Google Scholar] [CrossRef]
- Milton, A.C.; Ellis, L.A.; Davenport, T.A.; Burns, J.M.; Hickie, I.B. Comparison of Self-Reported Telephone Interviewing and Web-Based Survey Responses: Findings From the Second Australian Young and Well National Survey. JMIR Ment. Health 2017, 4, e37. [Google Scholar] [CrossRef] [PubMed]
- Global Adult Tobacco Survey Collaborative Group. Global Adult Tobacco Survey (GATS): Sample Design Manual, Version 2.0; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2010; Available online: http://www.who.int/tobacco/surveillance/en_tfi_gats_sampledesignmanual_v2_final_03nov2010.pdf (accessed on 14 July 2021).
- Kostygina, G.; Ling, P.M. Tobacco industry use of flavourings to promote smokeless tobacco products. Tob. Control 2016, 25 (Suppl. 2), ii40–ii49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- McKelvey, K.; Baiocchi, M.; Halpern-Felsher, B. PMI’s heated tobacco products marketing claims of reduced risk and reduced exposure may entice youth to try and continue using these products. Tob. Control 2020, 29, e18–e24. [Google Scholar] [CrossRef]
- OECD/European Observatory on Health Systems and Policies (2017). Poland: Country Health Profile 2017, State of Health in the EU; OECD Publishing: Paris, France; European Observatory on Health Systems and Policies: Brussels, Belgium, 2017. [Google Scholar]
- Jankowski, M.; Pinkas, J.; Zgliczyński, W.S.; Kaleta, D.; Wierzba, W.; Gujski, M.; Rees, V.W. Voluntary Smoke-Free Home Rules and Exposure to Secondhand Smoke in Poland: A National Cross-Sectional Survey. Int. J. Environ. Res. Public Health 2020, 17, 7502. [Google Scholar] [CrossRef]
- West, R. Tobacco smoking: Health impact, prevalence, correlates and interventions. Psychol. Health 2017, 32, 1018–1036. [Google Scholar] [CrossRef] [Green Version]
- Cruz, T.B.; Rose, S.W.; Lienemann, B.A.; Byron, M.J.; Meissner, H.I.; Baezconde-Garbanati, L.; Huang, L.L.; Carroll, D.M.; Soto, C.; Unger, J.B. Pro-tobacco marketing and anti-tobacco campaigns aimed at vulnerable populations: A review of the literature. Tob. Induc. Dis. 2019, 17, 68. [Google Scholar] [CrossRef]
- Mattes, W.; Yang, X.; Orr, M.S.; Richter, P.; Mendrick, D.L. Biomarkers of tobacco smoke exposure. Adv. Clin. Chem. 2014, 67, 1–45. [Google Scholar]
Characteristics | Total n = 1011 | Smokers n = 226 | Non-Smokers n = 785 | p |
---|---|---|---|---|
Weighted % (95%CI) | Weighted % (95%CI) | Weighted % (95%CI) | ||
Do you think that smoking causes serious diseases? | ||||
Yes | 83.6 (81.2–85.7) | 80.1 (74.4–84.8) | 84.6 (81.9–86.9) | 0.1 |
No | 10.6 (8.8–12.6) | 11.5 (8.0–16.3) | 10.3 (8.4–12.6) | |
I do not know | 5.8 (4.6–7.5) | 8.4 (5.5–12.8) | 5.1 (3.8–6.9) | |
Do you think that smoking causes stroke? | ||||
Yes | 70.4 (67.5–73.2) | 56.6 (50.1–62.9) | 74.4 (71.2–77.3) | <0.001 |
No | 15.7 (13.6–18.1) | 26.6 (21.2–32.7) | 12.6 (10.5–15.1) | |
I do not know | 13.9 (11.9–16.1) | 16.8 (12.5–22.2) | 13.0 (10.8–15.5) | |
Do you think that smoking causes myocardial infarction? | ||||
Yes | 81.4 (78.9–83.7) | 70.8 (64.6–76.3) | 84.5 (81.8–86.8) | <0.001 |
No | 10.3 (8.6–12.3) | 16.8 (12.5–22.2) | 8.4 (6.7–10.6) | |
I do not know | 8.3 (6.8–10.2) | 12.4 (8.7–17.3) | 7.1 (5.5–9.2) | |
Do you think that smoking causes lung cancer? | ||||
Yes | 88.9 (86.8–90.7) | 87.2 (82.2–90.9) | 89.4 (87.1–91.4) | 0.5 |
No | 7.5 (6.1–9.3) | 8.0 (5.1–12.2) | 7.4 (5.8–9.4) | |
I do not know | 3.6 (2.6–4.9) | 4.8 (2.7–8.5) | 3.2 (2.2–4.7) | |
Do you think that e-cigarette use causes serious diseases? | ||||
Yes | 57.9 (54.8–60.9) | 49.1 (42.7–55.6) | 60.4 (56.9–63.8) | 0.01 |
No | 14.3 (12.2–16.5) | 16.4 (12.1–21.8) | 13.7 (11.4–16.2) | |
I do not know | 27.8 (25.1–30.6) | 34.5 (28.6–40.9) | 25.9 (22.9–29.0) | |
Do you think that e-cigarette use causes stroke? | ||||
Yes | 54.4 (51.3–57.5) | 41.0 (34.8–47.5) | 58.2 (54.7–61.6) | <0.001 |
No | 15.9 (13.8–18.3) | 20.7 (15.9–26.4) | 14.5 (12.2–17.2) | |
I do not know | 29.7 (27.0–32.7) | 38.3 (32.3–44.8) | 27.3 (24.3–30.5) | |
Do you think that e-cigarette use causes myocardial infarction? | ||||
Yes | 59.4 (56.3–62.3) | 45.1 (38.8–51.7) | 63.4 (60.0–66.7) | <0.001 |
No | 12.5 (10.7–14.8) | 18.2 (13.7–23.7) | 11.0 (9.0–13.3) | |
I do not know | 28.1 (25.4–30.9) | 36.7 (30.7–43.2) | 25.6 (22.7–28.8) | |
Do you think that e-cigarette use causes lung cancer? | ||||
Yes | 65.8 (62.8–68.6) | 57.1 (50.6–63.4) | 68.3 (64.9–71.4) | 0.01 |
No | 11.1 (9.3–13.2) | 14.6 (10.6–19.8) | 10.0 (8.2–12.4) | |
I do not know | 23.1 (20.7–25.8) | 28.3 (22.9–34.5) | 21.7 (18.9–24.7) | |
Are you concerned about the harmful effect of passive smoking on your health? | ||||
I am very concerned | 9.2 (7.6–11.1) | 6.2 (3.7–10.1) | 10.0 (8.2–12.4) | <0.001 |
I am a little concerned | 38.4 (35.4–41.4) | 58.8 (52.3–65.1) | 32.5 (29.3–35.8) | |
I am not very concerned | 26.6 (24.0–29.4) | 25.7 (20.4–31.7) | 26.9 (23.9–30.1) | |
I am completely not concerned | 25.8 (23.2–28.6) | 9.3 (6.2–13.8) | 30.6 (27.5–33.9) |
Harmfulness of Selected Products | Menthol Cigarettes | Flavored Cigarettes (Except Menthol) | Slim Cigarettes | Cigarillos | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Less Harmful | As Harmful | More Harmful | Less Harmful | As Harmful | More Harmful | Less Harmful | As Harmful | More Harmful | Less Harmful | As Harmful | More Harmful | ||
Overall | % * | 15.6 | 80.4 | 4.0 | 16.1 | 80.0 | 3.9 | 17.1 | 80.0 | 2.9 | 12.6 | 83.1 | 4.3 |
n = 1011 | 95%CI | 13.5–18.0 | 77.9–82.7 | 2.9–5.3 | 14.0–18.5 | 77.3–82.3 | 2.8–5.2 | 14.9–19.6 | 77.4–82.4 | 2.0–4.1 | 10.7–14.8 | 80.7–85.3 | 3.2–5.7 |
Smokers | % * | 19.9 | 73.9 | 6.2 | 17.8 | 76.0 | 6.2 | 20.8 | 76.1 | 3.1 | 13.8 | 79.6 | 6.6 |
n = 226 | 95%CI | 15.2–25.6 | 67.8–79.2 | 3.7–10.1 | 13.3–23.3 | 70.0–81.1 | 3.7–10.2 | 16.0–26.6 | 70.1–81.2 | 1.5–6.3 | 9.9–18.9 | 73.8–84.3 | 4.1–10.7 |
Non-smokers | % * | 14.4 | 82.3 | 3.3 | 15.7 | 81.1 | 3.2 | 16.1 | 81.1 | 2.8 | 12.2 | 84.2 | 3.6 |
n = 785 | 95%CI | 12.1–17.0 | 79.5–84.8 | 2.3–4.8 | 13.3–18.4 | 78.3–83.7 | 2.2–4.7 | 13.7–18.8 | 78.3–83.7 | 1.9–4.2 | 10.1–14.7 | 81.5–86.6 | 2.5–5.1 |
p | 0.01 | 0.07 | 0.2 | 0.1 | |||||||||
Harmfulness of Selected Products | Smokeless Tobacco | Water Pipe (shisha) | E-Cigarettes | Heated Tobacco Products | |||||||||
Less Harmful | As Harmful | More Harmful | Less Harmful | As Harmful | More Harmful | Less Harmful | As Harmful | More Harmful | Less Harmful | As Harmful | More Harmful | ||
Overall | % * | 25.0 | 71.7 | 3.3 | 24.5 | 71.1 | 4.4 | 21.6 | 70.0 | 8.4 | 22.0 | 71.8 | 6.2 |
n = 1011 | 95%CI | 22.5–27.8 | 68.8–74.4 | 2.3–4.6 | 22.0–27.3 | 68.2–73.8 | 3.3–5.9 | 19.1–24.2 | 67.1–72.8 | 6.9–10.3 | 19.5–24.6 | 69.0–74.5 | 4.9–7.9 |
Smokers | % * | 32.3 | 63.7 | 4.0 | 32.3 | 62.0 | 5.7 | 28.6 | 61.7 | 9.7 | 24.8 | 66.8 | 8.4 |
n = 226 | 95%CI | 26.5–38.7 | 57.3–69.7 | 2.1–7.4 | 26.5–38.7 | 55.5–68.0 | 3.4–9.6 | 23.2–34.8 | 55.2–67.8 | 6.5–14.2 | 19.6–30.8 | 60.4–72.6 | 5.5–12.8 |
Non-smokers | % * | 22.9 | 74.0 | 3.1 | 22.3 | 73.6 | 4.1 | 19.5 | 72.4 | 8.1 | 21.2 | 73.3 | 5.5 |
n = 785 | 95%CI | 20.2–26.0 | 70.8–76.9 | 2.1–4.5 | 19.5–25.3 | 70.5–76.6 | 2.9–5.7 | 16.9–22.4 | 69.1–75.4 | 6.3–10.1 | 18.4–24.1 | 70.0–76.2 | 4.2–7.4 |
p | 0.01 | 0.003 | 0.01 | 0.1 |
Variable | Smoking Causes Stroke | Smoking Causes Myocardial Infarction | E-Cigarette Use Causes Serious Diseases | |||
---|---|---|---|---|---|---|
Univariate Logistic Regression | Multivariate Logistic Regression | Univariate Logistic Regression | Multivariate Logistic Regression | Univariate Logistic Regression | Multivariate Logistic Regression | |
OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | OR (95%CI) | |
Smoking status | ||||||
smoker | 0.45 (0.33–0.61) ** | 0.43 (0.31–0.59) ** | 0.44 (0.31–0.62) ** | 0.41 (0.29–0.60) ** | 0.64 (0.47–0.86) * | 0.63 (0.46–0.86) * |
non-smoker | Reference | Reference | Reference | Reference | Reference | Reference |
Gender | ||||||
female | Reference | Reference | Reference | Reference | Reference | Reference |
male | 0.92 (0.71–1.21) | 1.00 (0.75–1.33) | 0.95 (0.69–1.30) | 1.13 (0.81–1.59) | 0.91 (0.71–1.17) | 0.95 (0.73–1.23) |
Age (years) | ||||||
15–19 | 0.75 (0.42–1.33) | 0.56 (0.30–r1.05) | 0.52 (0.28–0.99) * | 0.35 (0.17–0.70) * | 0.93 (0.55–1.61) | 0.93 (0.52–1.68) |
20–29 | 1.19 (0.77–1.84) | 1.18 (0.73–1.93) | 0.95 (0.57–1.58) | 0.93 (0.52–1.66) | 0.88 (0.60–1.30) | 0.76 (0.49–1.18) |
30–39 | 1.02 (0.68–1.53) | 1.17 (0.72–1.91) | 0.84 (0.52–1.35) | 0.93 (0.53–1.66) | 1.22 (0.84–1.78) | 1.15 (0.74–1.80) |
40–49 | 1.05 (0.68–1.63) | 1.22 (0.73–2.04) | 0.84 (0.50–1.41) | 1.03 (0.56–1.88) | 1.28 (0.85–1.93) | 1.25 (0.78–2.01) |
50–59 | 0.89 (0.59–1.36) | 1.02 (0.63–1.65) | 0.93 (0.56–1.55) | 1.15 (0.64–2.07) | 1.10 (0.75–1.63) | 1.08 (0.69–1.68) |
60+ | Reference | Reference | Reference | Reference | Reference | Reference |
Educational level | ||||||
primary | 0.87 (0.57–1.32) | 1.10 (0.65–1.85) | 0.72 (0.43–1.20) | 1.13 (0.60–2.12) | 0.69 (0.47–1.01) | 0.90 (0.56–1.45) |
vocational | 0.79 (0.54–1.18) | 0.92 (0.59–1.44) | 0.52 (0.33–0.84) * | 0.67 (0.39–1.14) | 0.70 (0.49–1.01) | 0.88 (0.58–1.33) |
secondary | 1.05 (0.72–1.53) | 1.10 (0.74–1.65) | 0.82 (0.51–1.31) | 0.92 (0.56–1.52) | 1.07 (0.75–1.51) | 1.26 (0.87–1.82) |
higher | Reference | Reference | Reference | Reference | Reference | Reference |
Occupational status | ||||||
active | Reference | Reference | Reference | Reference | Reference | Reference |
passive | 0.95 (0.72–1.26) | 1.09 (0.73–1.63) | 1.02 (0.73–1.41) | 1.30 (0.82–2.08) | 0.83 (0.64–1.07) | 0.99 (0.69–1.42) |
Financial situation | ||||||
bad | 0.84 (0.58–1.23) | 0.90 (0.59–1.38) | 0.46 (0.28–0.74) ** | 0.48 (0.28–0.81) * | 0.61 (0.43–0.88) * | 0.71 (0.48–1.05) |
moderate | 1.09 (0.78–1.54) | 1.21 (0.83–1.76) | 0.58 (0.37–0.92) * | 0.66 (0.41–1.08) | 0.66 (0.47–0.91) * | 0.73 (0.51–1.03) |
good | Reference | Reference | Reference | Reference | Reference | Reference |
Place of residence | ||||||
rural | 1.12 (0.85–1.48) | 1.09 (0.82–1.45) | 0.76 (0.55–1.04) | 0.77 (0.55–1.08) | 0.86 (0.66–1.10) | 0.87 (0.67–1.14) |
urban | Reference | Reference | Reference | Reference | Reference | Reference |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Jankowski, M.; Wrześniewska-Wal, I.; Ostrowska, A.; Lusawa, A.; Wierzba, W.; Pinkas, J. Perception of Harmfulness of Various Tobacco Products and E-Cigarettes in Poland: A Nationwide Cross-Sectional Survey. Int. J. Environ. Res. Public Health 2021, 18, 8793. https://doi.org/10.3390/ijerph18168793
Jankowski M, Wrześniewska-Wal I, Ostrowska A, Lusawa A, Wierzba W, Pinkas J. Perception of Harmfulness of Various Tobacco Products and E-Cigarettes in Poland: A Nationwide Cross-Sectional Survey. International Journal of Environmental Research and Public Health. 2021; 18(16):8793. https://doi.org/10.3390/ijerph18168793
Chicago/Turabian StyleJankowski, Mateusz, Iwona Wrześniewska-Wal, Aurelia Ostrowska, Aleksandra Lusawa, Waldemar Wierzba, and Jarosław Pinkas. 2021. "Perception of Harmfulness of Various Tobacco Products and E-Cigarettes in Poland: A Nationwide Cross-Sectional Survey" International Journal of Environmental Research and Public Health 18, no. 16: 8793. https://doi.org/10.3390/ijerph18168793
APA StyleJankowski, M., Wrześniewska-Wal, I., Ostrowska, A., Lusawa, A., Wierzba, W., & Pinkas, J. (2021). Perception of Harmfulness of Various Tobacco Products and E-Cigarettes in Poland: A Nationwide Cross-Sectional Survey. International Journal of Environmental Research and Public Health, 18(16), 8793. https://doi.org/10.3390/ijerph18168793